Regenera Activa for Hair Loss: What Is Known and Unproven

You notice your parting growing wider, and overhead lighting makes more scalp visible in photographs. Searching brings up Regenera Activa, with claims that your own tissue can “restore” hair. An interesting technique should not be mistaken for a proven answer to every cause of hair loss. Regenera Activa is an approach using autologous scalp micrografts, investigated mainly for patterned hair thinning. It does not create new hair follicles or guarantee your former density. Before considering injections, find out why your own hair is thinning.

What exactly is Regenera Activa, and what does the device do?

Regenera Activa is marketed as an AMT (Autologous Micrografting Technology) protocol using tiny grafts made from the patient's own tissues. Small samples are usually taken from a relatively well-haired scalp area, mechanically processed with the Rigenera system and single-use components, and the resulting suspension is injected into thinning areas. “Autologous” means taken from the same person. This is not transplantation of individual follicular units, as in hair surgery, and not a simple vitamin injection.

The manufacturer describes progenitor cells, extracellular matrix and signalling particles, sometimes called exosomes. Their proposed action concerns the local environment of follicles that are still present. But detecting biological components in a mixture does not establish that each has the claimed effect in humans. Treat promotional “exosomes per session” counts, “stem-cell” slogans and claims to awaken follicles that have completely disappeared with particular caution: particle counts do not equal clinical hair regrowth.

Names can be confusing. Regenera Activa may refer to the commercial protocol, Rigenera to the tissue-processing device and Rigeneracons to a disposable processing component. At a consultation, ask for the exact device, disposable kit and protocol names. The same wording on a sign does not confirm identical equipment or authorized indications.

Which pattern of hair loss might justify discussing it?

The best-studied situation is a gradually widening central part in female pattern hair loss, also called female androgenetic alopecia. Follicles may keep functioning but produce progressively thinner, miniaturized hairs. Small clinical studies of micrografts enrolled people with an established diagnosis rather than anyone reporting “shedding.”

A different situation is sudden heavy shedding several months after fever, childbirth, rapid weight loss or severe stress. This can be telogen effluvium; evaluating the trigger and monitoring recovery generally come first. Discrete round patches, scaling, severe itch, burning, pain or scarred patches lacking visible follicle openings need a dermatologist's assessment: autoimmune, fungal or scarring alopecia may be involved. Delaying care for some scarring forms can cause permanent follicle loss.

Your situation	What to clarify before Regenera Activa	A sensible first step
The part has widened over years and hairs have become finer	Does trichoscopy show miniaturization, and how fast is density changing?	Confirm female pattern hair loss and discuss approaches with stronger supporting evidence
Shedding began suddenly after an event or illness	Could this be temporary telogen shedding or a relevant deficiency?	Review the history; order tests when indicated rather than rushing into injections
Redness, pain, crusting or hairless patches	Could there be inflammation, infection or scarring alopecia?	In-person dermatology diagnosis before aesthetic procedures
A patch has been completely smooth for a long time	Are functioning follicles still present?	Do not expect a micrograft suspension to create new follicles; explore other options

A doctor can perform trichoscopy (magnified scalp examination), compare standardized images, and ask about family history, medication, menstrual cycles, nutrition and other symptoms. Iron, thyroid or hormonal tests are guided by the clinical picture, not obligatory for everybody. You may defer the decision if Regenera Activa is proposed without scalp examination and a diagnosis.

What do studies show, and what remains unproven?

A 2024 paper followed 23 women with confirmed androgenetic alopecia six months after one autologous micrograft treatment. The authors reported improvement based on photographic assessment. This is a preliminary signal, but the small study without a robust control group cannot reliably separate treatment effects from natural changes, other care or assessment bias.

A 2025 review of micrografting studies also described density improvements in some studies, while pointing to differing protocols and potential bias. A 2026 consensus statement from the Association of Cutaneous Surgeons of India graded the evidence for this approach in androgenetic alopecia at level 4, with a grade C recommendation. This reflects limited strength of evidence, not a promise of benefit for an individual patient. Among the publications reviewed through October 2026, large, rigorous randomized trials have not established an advantage for this method, and reliable long-term maintenance schedules remain undefined. It cannot support a promise of a particular number of new hairs from one treatment. Apparent results depend on starting hair diameter, stage of thinning, counting methods and any medicines taken at the same time.

An essential distinction: medical-device registration or marking establishes a particular regulatory status, not proven efficacy of the brand against all forms of hair loss in every country. Manufacturer statements about CE marking or other certificates do not replace checking the actual model, approved purpose, jurisdiction and certificate validity. This article has not verified authorization of Regenera Activa for alopecia treatment in Armenia; European materials and mentions of the US FDA do not establish it.

What happens at a session, and what will be visible afterward?

After diagnosis and informed consent, the practitioner plans the donor area, anesthesia and injection sites. Removing small pieces of skin is a biopsy, not a needle-free facial-style treatment. The tissue is processed into a suspension and injected at multiple scalp sites. Sample number, technique and duration depend on the equipment and medical plan; do not treat an online video as a set of instructions. Ask how equipment is sterilized or replaced and how the collected tissue is handled.

You may feel pressure or discomfort at biopsy sites and stinging or pain from injections despite local anesthesia. Afterward there may be dots, redness, traces of blood, swelling or scalp tenderness. Donor sites can show, especially with short hair or an updo. Hair may temporarily clump from solution or cleansing. Leaving the clinic the same day does not mean that nothing will show in photographs.

A quiet working day afterward can be easier than recovery after full surgical hair transplantation, but nobody can promise the same timetable to everyone. Leave a buffer before an important event. Ask your clinician exactly when you may wash or color your hair, exercise, swim and use styling products following their technique. Do not rub or scratch biopsy sites before receiving instructions; irritating serums will not speed healing.

When should you judge results rather than trust photographs?

Hair follows a long growth cycle; you should not expect true new density the day after injections. Studies assess outcomes over months, not hours or one week. Ordinary variations in shedding and styling can occur in between. Agree in advance what counts as success: a stable part width, hair count per area, shaft diameter or the feeling of fullness are different endpoints.

Request before-and-after images with the same part, hair length, lighting and camera distance, without concealing fibers. “After” photographs sometimes have less glare, different styling or darker dye, which can create an impression of density. A striking social-media story does not predict your chance of success. A separate page on evaluating Regenera Activa reviews discusses patient accounts, but reviews are no substitute for measurements and diagnosis.

If repeat visits are offered on a fixed calendar, ask which study supports that particular schedule, what happens if no benefit is seen, and how many months are allowed for evaluation. A universal repeat-treatment schedule for every stage of female pattern thinning has not been established. Agreeing to one session does not commit you to buying a course.

Which limitations and risks deserve attention?

Using your own tissue avoids some incompatibility issues associated with donor tissue from someone else; it does not make the procedure risk-free. Biopsies and injections can cause bleeding, bruising, pain, infection, inflammation, small scars and reactions to local anesthetics. Keloid tendency, bleeding disorders, anticoagulants, active scalp infection and serious medical conditions call for individual assessment. Never stop prescribed medication, particularly blood-thinning medication, on your own for an elective procedure.

Reliable benefit and safety data for this elective procedure during pregnancy or breastfeeding are lacking; postponing and discussing the hair loss with a clinician is preferable, especially after childbirth. People undergoing cancer or autoimmune treatment need advice from their treating specialist, not a promise that a “completely natural” method is universally safe. These precautions are not a single official contraindication list for every device version: the actual kit's instructions and the individual patient's condition must be checked.

Increasing pain, worsening redness or swelling, pus, fever or bleeding that does not stop call for prompt medical contact; marked general illness calls for emergency care. These are different from mild short-lived tenderness at injection points. You should leave with out-of-hours contact details and clear donor-site care instructions.

What should you compare it with, and when is declining reasonable?

For female pattern hair loss, a long-term plan matters more than finding the most novel procedure. Topical minoxidil is among the better-studied approaches; benefit develops gradually and usually requires continued use to maintain it. Other medications depend on medical indications, age, pregnancy considerations and health. If iron deficiency or thyroid disease is relevant, the underlying cause needs attention.

PRP is platelet-rich plasma prepared from your own blood, not the scalp-tissue micrograft material or process described here. Hair Filler Dr. CYJ is another distinct injection concept; its characteristics cannot be attributed to Regenera Activa. Hair transplantation physically moves follicles from one area to another, is more invasive and requires sufficient donor hair; Regenera does not do this. Concealing products, appropriate styling or choosing to do nothing for now remain legitimate options when hair loss is stable and there are no concerning medical signs.

When comparing costs, ask about assessment, disposable biopsy equipment, anesthetic, follow-up visits and possible repeats, not just the quoted session price. Neither local pricing nor availability of Regenera Activa at a particular Yerevan center has been verified here. That means asking to see documentation, not assuming the technology is absent from the country.

What should you ask at your consultation?

What is my actual diagnosis, confirmed by examination, trichoscopy and tests when indicated? Are there signs of inflammatory or scarring alopecia?
What is the exact Rigenera device and disposable kit? Can I see current instructions, local marketing documentation and the practitioner's relevant training?
How much tissue will be taken and from where? What anesthesia will be used, what will show through my hair, and how is the sample processed?
Which independent studies support expectations for my sex, stage of thinning and existing treatment? What will you objectively measure after several months?
What is the plan for complications, donor care, exercise and hair coloring restrictions, and the complete cost including checks?
What would I lose by establishing the diagnosis first or starting better-supported maintenance therapy and revisiting this option later?

A sound consultation permits “not now.” If the explanation starts with a promise to wake every dormant follicle but never addresses the diagnosis, taking time is reasonable. The goal is not to purchase a technology name; it is to judge whether the evidence plausibly applies to your own type of hair loss.

Frequently asked questions

Must the entire head be shaved to obtain tissue?

That depends on the planned donor zone and sampling technique. Ask in advance exactly which small patch might be clipped or exposed and how it can be hidden with your usual hairstyle.

Can this be done while using minoxidil?

Some studies involve combined treatment, but effects cannot automatically be added together. Do not change your prescribed routine without your dermatologist; agree how to interpret results when multiple treatments are used.

What if density has not improved after several months?

Compare standardized photographs and trichoscopy, and reassess diagnosis and other causes of shedding. Lack of improvement does not automatically justify another paid session; repeating treatment needs its own rationale.